{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:32:59Z","timestamp":1793251979910,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI191384"],"award-info":[{"award-number":["AI191384"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD036329"],"award-info":[{"award-number":["S10 OD036329"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD020012"],"award-info":[{"award-number":["S10 OD020012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM131839"],"award-info":[{"award-number":["R35 GM131839"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI090959"],"award-info":[{"award-number":["AI090959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD034375-01"],"award-info":[{"award-number":["1S10OD034375-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30 DK131853"],"award-info":[{"award-number":["F30 DK131853"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI146248"],"award-info":[{"award-number":["AI146248"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UO1 AI153612"],"award-info":[{"award-number":["UO1 AI153612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.healun.2026.10.003","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:11:48Z","timestamp":1791558708000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ex vivo machine perfusion enables robust and widespread lipophilic-conjugated siRNA delivery to the porcine lung"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-471X","authenticated-orcid":false,"given":"Julianna E.","family":"Buchwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Tocheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-318X","authenticated-orcid":false,"given":"Hussein","family":"Kharroubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0215-9179","authenticated-orcid":false,"given":"Bassel","family":"Tfayli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sanatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3102-7350","authenticated-orcid":false,"given":"Sara","family":"De Taeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vella M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3664-2094","authenticated-orcid":false,"given":"William","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-0993","authenticated-orcid":false,"given":"Hassan H.","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-097X","authenticated-orcid":false,"given":"Asishana","family":"Osho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Khvorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Alireza","family":"Rabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2026.10.003_bib1","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.1016\/j.ajt.2024.01.017","article-title":"OPTN\/SRTR 2022 annual data report: lung","volume":"24","author":"Valapour","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib2","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1016\/j.ajt.2025.01.025","article-title":"OPTN\/SRTR 2023 annual data report: lung","volume":"25","author":"Valapour","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib3","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.21037\/jtd-2021-18","article-title":"Primary graft dysfunction: what we know","volume":"13","author":"Clausen","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2026.10.003_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0033-1348474","article-title":"Primary graft dysfunction","volume":"34","author":"Suzuki","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2026.10.003_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.healun.2017.07.013","article-title":"Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: a 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation","volume":"36","author":"Van Raemdonck","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2022.05.013","article-title":"Cell death and ischemia-reperfusion injury in lung transplantation","volume":"41","author":"Capuzzimati","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2026.10.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/jtd-23-1618","article-title":"Primary graft dysfunction in lung transplantation: still a thorn in the side of lung transplant","volume":"16","author":"Wong","year":"2024","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2026.10.003_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.12659\/MSMBR.893674","article-title":"Ex vivo lung perfusion \u2013 state of the art in lung donor pool expansion","volume":"21","author":"Popov","year":"2015","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.healun.2026.10.003_bib10","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/ajt.14339","article-title":"A multicenter study on long-term outcomes after lung transplantation comparing donation after circulatory death and donation after brain death","volume":"17","author":"van Suylen","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1513546","article-title":"Ex vivo lung perfusion: recent advancements and future directions","volume":"16","author":"Nakata","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2026.10.003_bib12","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/TP.0000000000003295","article-title":"Review of current machine perfusion therapeutics for organ preservation","volume":"104","author":"Xu","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.10.003_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA interference therapeutic agent for hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.healun.2026.10.003_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2026.10.003_bib15","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.healun.2026.10.003_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.healun.2026.10.003_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.healun.2026.10.003_bib18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/nar\/gky1232","article-title":"Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways","volume":"47","author":"Osborn","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.healun.2026.10.003_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.healun.2026.10.003_bib20","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/jama.2023.4570","article-title":"siRNAs-a new class of medicines","volume":"329","author":"Khvorova","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.healun.2026.10.003_bib21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00011-022-01651-6","article-title":"Immune response associated with ischemia and reperfusion injury during organ transplantation","volume":"71","author":"Tang","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.healun.2026.10.003_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167082","article-title":"JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunction","volume":"8","author":"Khatri","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2026.10.003_bib23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jcph.2325","article-title":"Inhibitors in solid organ transplantation","volume":"63","author":"Assadiasl","year":"2023","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.healun.2026.10.003_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02222-2019","article-title":"Potential therapeutic targets for lung repair during human ex vivo lung perfusion","volume":"55","author":"Wong","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.10.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102117","article-title":"Multispecies-targeting siRNAs for the modulation of JAK1 in the skin","volume":"35","author":"Tang","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.healun.2026.10.003_bib26","doi-asserted-by":"crossref","DOI":"10.3791\/66624","article-title":"Cardiac loading using passive left atrial pressurization and passive afterload for graft assessment","author":"Olverson","year":"2024","journal-title":"J Vis Exp"},{"key":"10.1016\/j.healun.2026.10.003_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-61779-845-0_11","article-title":"Xenogeneic lung transplantation models","volume":"885","author":"Burdorf","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.healun.2026.10.003_bib28","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1038\/s41467-023-42714-4","article-title":"Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin","volume":"14","author":"Tang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2026.10.003_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/nat.2019.0840","article-title":"RT-qPCR Methods to support pharmacokinetics and drug mechanism of action to advance development of RNAi therapeutics","volume":"30","author":"Castellanos-Rizaldos","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.healun.2026.10.003_bib30","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.ajt.2025.07.179","article-title":"A change of heart: siRNA-mediated gene silencing and delivery during ex vivo heart perfusion for organ optimization","volume":"25","author":"Buchwald","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib31","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.healun.2024.02.106","article-title":"Optimizing hearts for transplantation using small interfering RNA-based therapies during ex vivo machine perfusion","volume":"43","author":"Buchwald","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.healun.2017.07.014","article-title":"Report of the ISHLT working group on primary lung graft dysfunction part III: mechanisms: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation","volume":"36","author":"Gelman","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit care Med"},{"key":"10.1016\/j.healun.2026.10.003_bib34","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.healun.2016.04.017","article-title":"Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation","volume":"35","author":"Mordant","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib35","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"306","author":"McAuley","year":"2014","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2026.10.003_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0704-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death","volume":"18","author":"Stone","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.healun.2026.10.003_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000266","article-title":"Functional repair of human donor lungs by IL-10 gene therapy","volume":"1","author":"Cypel","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2026.10.003_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm7190","article-title":"Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs","volume":"14","author":"Wang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2026.10.003_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/hum.2016.070","article-title":"Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model","volume":"28","author":"Machuca","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.healun.2026.10.003_bib40","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.healun.2007.07.033","article-title":"Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors","volume":"26","author":"Inci","year":"2007","journal-title":"J Heart lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib41","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.athoracsur.2014.01.076","article-title":"Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system","volume":"98","author":"Inci","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2026.10.003_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/hum.2018.117","article-title":"Immunoengineering of the vascular endothelium to silence MHC expression during normothermic ex vivo lung perfusion","volume":"30","author":"Figueiredo","year":"2019","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.healun.2026.10.003_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi9548","article-title":"Knockdown of swine leukocyte antigen expression in porcine lung transplants enables graft survival without immunosuppression","volume":"16","author":"Figueiredo","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2026.10.003_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.healun.2026.10.003_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164816","article-title":"MicroRNA-1 protects the endothelium in acute lung injury","volume":"8","author":"Korde","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2026.10.003_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081793","article-title":"Transcriptomic signatures in lung allografts and their therapeutic implications","volume":"12","author":"Guinn","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.healun.2026.10.003_bib47","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.healun.2024.02.022","article-title":"CRISPR-cas genome editing in ex vivo human lungs","volume":"43","author":"Mesaki","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.10.003_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12931-024-02776-4","article-title":"The endothelium: gatekeeper to lung ischemia-reperfusion injury","volume":"25","author":"Ta","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.healun.2026.10.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113862","article-title":"In vitro and ex vivo models in inhalation biopharmaceutical research \u2014 advances, challenges and future perspectives","volume":"177","author":"Selo","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.healun.2026.10.003_bib50","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mucimm.2025.04.001","article-title":"Innate immunity of the lungs in homeostasis and disease","volume":"18","author":"Norris","year":"2025","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.healun.2026.10.003_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","author":"Hariharan","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2026.10.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102230","article-title":"Phosphatidylcholine head group chemistry alters the extrahepatic accumulation of lipid-conjugated siRNA","volume":"35","author":"Hariharan","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.healun.2026.10.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100192","article-title":"Ex vivo delivery of recombinant IL-10 to human donor lungs","volume":"7","author":"Yeung","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2026.10.003_bib54","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ymthe.2020.12.023","article-title":"Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles","volume":"29","author":"Biscans","year":"2021","journal-title":"Mol Ther"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826021339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826021339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:02:10Z","timestamp":1793250130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249826021339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"alternative-id":["S1053249826021339"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.10.003","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo machine perfusion enables robust and widespread lipophilic-conjugated siRNA delivery to the porcine lung","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}